| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.85B | 53.92B | 52.77B | 48.60B | 49.06B | 46.25B |
| Gross Profit | 9.19B | 9.35B | 9.28B | 6.20B | 8.54B | 5.27B |
| EBITDA | 7.02B | 7.34B | 7.73B | 4.82B | 6.68B | 3.15B |
| Net Income | 2.59B | 2.95B | 1.77B | 788.00M | 2.84B | -1.31B |
Balance Sheet | ||||||
| Total Assets | 45.79B | 44.89B | 46.36B | 43.06B | 42.94B | 44.35B |
| Cash, Cash Equivalents and Short-Term Investments | 8.39B | 7.98B | 5.20B | 3.71B | 2.98B | 2.83B |
| Total Debt | 508.83M | 580.35M | 2.39B | 5.15B | 7.02B | 10.62B |
| Total Liabilities | 19.07B | 18.25B | 21.70B | 22.51B | 24.24B | 28.33B |
| Stockholders Equity | 26.70B | 26.64B | 24.66B | 20.55B | 18.70B | 16.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.99B | 4.41B | 2.99B | 3.24B | -896.67M |
| Operating Cash Flow | 0.00 | 7.18B | 6.56B | 5.24B | 5.44B | 2.95B |
| Investing Cash Flow | 0.00 | -2.29B | -2.11B | -2.45B | -1.63B | -3.81B |
| Financing Cash Flow | 0.00 | -2.10B | -3.03B | -2.10B | -3.83B | 529.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥26.04B | 14.38 | ― | 4.20% | -1.15% | -34.09% | |
76 Outperform | ¥16.79B | 4.18 | ― | 1.67% | -4.44% | -17.38% | |
75 Outperform | ¥13.69B | 6.74 | ― | 3.90% | -1.72% | 168.62% | |
71 Outperform | ¥18.75B | 8.04 | ― | 2.70% | -8.63% | -55.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥18.89B | 18.77 | ― | 3.19% | -8.99% | -62.26% | |
47 Neutral | ¥24.86B | -5.63 | ― | 3.33% | -3.91% | -36.53% |